It is tempting to speculate that a similar effect of AGR2 in human tumours may account for the late effect on patient outcome found in the ERα-positive group in this study; the survival curves do not begin to separate until approximately 40 months and become significant only at 6 years. This evidence concerns the gene AGR2 and neoplasm.